PEP trial. Pulmonary Embolism Prevention.
Cohen
A
A
Quinlan
D
D
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D002423:Cause of Death; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019106:Postoperative Hemorrhage / Q000209:etiology; D011655:Pulmonary Embolism / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012307:Risk Factors; D018401:Sample Size; D013923:Thromboembolism / Q000517:prevention & control; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin